MAPT and amyloidosis: The DMN emerged as a common locus across all three biomarkers—a pattern fully consistent with its vulnerability to tau spread and its known coupling with amyloid pathology (Braak & Braak, 1991; Schöll et al., 2016; Busche & Hyman, 2020).